Regulation · Safety standard
FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices
FDA finalized guidance on Predetermined Change Control Plans (PCCPs), allowing AI/ML medical device manufacturers to make pre-approved modifications without full resubmission. Requires documented modification protocol, impact assessment, and post-market monitoring. Over 1,350 AI-enabled devices authorized by FDA as of 2026.
Jurisdiction: United States · Effective 2024-12-01
Machine-readable surfaces
- Markdown mirror: /regulations/fda-pccp-final-guidance-2024.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/regulations/f53f5fb8-da84-4cf2-ad8d-2b4a3af5dc01
- Data documentation: /data
- Query this programmatically: Deploy MCP
Sources (1)
Status history
- In effect · 2024-12-01 · agent-recon
Initial ingestion
Common questions
What does FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices cover?
FDA finalized guidance on Predetermined Change Control Plans (PCCPs), allowing AI/ML medical device manufacturers to make pre-approved modifications without full resubmission. Requires documented modification protocol, impact assessment, and post-market monitoring. Over 1,350 AI-enabled devices authorized by FDA as of 2026.
Where does FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices apply?
FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices is recorded as a safety_standard applying in United States on the DEPLOY registry.
When did FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices take effect?
FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices is recorded as effective December 1, 2024 on the DEPLOY registry.
Is FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices still in effect?
FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices is currently in effect and applies to covered operators in the named jurisdiction.
What types of robots does FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices apply to?
FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices is recorded as applying to surgical, biometric, wearable on the DEPLOY registry.
Which robot models on the DEPLOY registry fall under FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices?
8 robot models on the DEPLOY registry match the form-factor scope of FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices: AI Pin, ANOVO, AirGo Vision, Amazfit (Balance / Active / T-Rex / Helio) and 4 others. Form-factor scope match does not by itself establish compliance status; review the underlying primary sources for each operator.
Methodology: Unreviewed · 1 source (no primary) · last reviewed 2026-08-09
Verification posture
Unreviewed
Low confidence
Review state
Stable
Last reviewed 2026-08-09
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for FDA Final Guidance: Predetermined Change Control Plans for AI/ML-Enabled Devices.Canonical ID f53f5fb8-da84-4cf2-ad8d-2b4a3af5dc01